Encision Inc. filings document the company’s Exchange Act reporting status, common-stock registration matters, and material corporate events. The Form 15-12G records Encision’s certification and notice to terminate registration under Section 12(g) and suspend reporting duties for its common stock.
Recent Form 8-K disclosures cover the company’s plan to deregister, its OTC-traded common stock, board and executive changes, and related exhibit filings. The filing record also identifies Encision as a Colorado issuer with common stock, no par value, under the ECIA trading symbol.
Encision Inc. plans to deregister its common stock and stop filing regular reports with the SEC. The company announced that it intends to file a Form 15, which will start the deregistration process for its common stock.
The deregistration is expected to become effective ninety days after the Form 15 is filed. Once effective, Encision will suspend its ongoing reporting obligations, meaning investors will no longer receive quarterly and annual SEC filings. The company’s decision was disclosed in a current report and related press release.
Encision, Inc. announced that Gregory Trudel resigned from its board of directors and also stepped down as CEO, President and executive officer effective December 8, 2025. The company states that Mr. Trudel disagreed with the other board members on the future direction of the company and concluded it was best to resign, while emphasizing that, apart from this difference over future direction, his resignation did not stem from any dispute over current operations, policies or practices.
Following his departure, the board appointed long-time director Robert H. Fries as Interim President and CEO. Mr. Fries, age 77, has served on Encision’s board since 2003, is a certified public accountant (inactive), and has extensive finance and tax consulting experience with large public multinational companies, which the company cites as qualifications for his interim leadership role.
Encision Inc. (ECIA) reported an insider equity award to its chief executive officer and director, Brandon Shepard. On 11/18/2025, he received an option to buy 10,000 shares of Encision common stock at an exercise price of $0.25 per share, expiring on 02/17/2031. The award is reported as directly owned.
The option vests over time: 20% of the shares vest after the first year of service on 11/18/2026, and the remaining shares vest in 48 equal monthly installments thereafter. This filing documents the grant and outlines the vesting schedule but does not include any sales of stock.
Encision Inc. director equity grant: Director Brandon Shepard reported receiving a stock option award from Encision Inc. (ticker ECIA) on 11/18/2025. The option gives him the right to buy 10,000 shares of Encision common stock at an exercise price of $0.25 per share.
The option expires on 02/17/2031. The grant vests over time, with 33% vesting after the first year of service on 11/18/2026 and the remaining portion vesting in 36 equal installments thereafter. Following this transaction, Shepard beneficially owns 10,000 derivative securities directly.
Encision Inc. (ECIA) reported a new equity award to an executive. Vice President of Marketing Brandon Shepard received an option on 10,000 shares of Encision common stock on 11/18/2025 at an exercise price of $0.25 per share. The option expires on 02/17/2031. The award vests 20% after one year of service on 11/18/2026, with the remaining shares vesting in 48 equal installments thereafter, so the grant becomes exercisable gradually over time while he remains in service.